BCCIP

gene product
BCCIPalpha, TOK-1
This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
141 antibodies from 24 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Proteintech Group
1 antibody
Invitrogen Antibodies
3 antibodies
Novus Biologicals
6 antibodies
antibodies-online
60 antibodies
LifeSpan BioSciences, Inc.
14 antibodies
GeneTex
2 antibodies
Aviva Systems Biology
2 antibodies
NovoPro Bioscience Inc.
1 antibody
OriGene
1 antibody
Affinity Biosciences
1 antibody
Abnova Corporation
5 antibodies
Biorbyt
8 antibodies
Signalway Antibody LLC
1 antibody
Bethyl Laboratories
3 antibodies
St John's Laboratory
2 antibodies
Acris Antibodies GmbH
4 antibodies
Atlas Antibodies
1 antibody
RabMAbs
1 antibody
MyBioSource
4 antibodies
Creative Diagnostics
3 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Sigma-Aldrich
1 antibody
Creative Biolabs
1 antibody